drugset
drugset / Trial / NCT02445404

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

NCT02445404 ↗

Phase 2 Unknown 134 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a Randomized Phase II Study to Compare Efficacy of CHOP versus Fractionated ICED in Transplant-eligible Patients with Previously Untreated Peripheral T-cell Lymphoma.

Timeline

Start
2015-09-23
Primary completion
2022-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 5 unknown Intravenous
Subject Cyclophosphamide Other / unclassified 750 mg/m2 Intravenous
Subject Dexamethasone Small molecule 40 mg Oral
Subject Doxorubicin Other / unclassified 50 mg/m2 Intravenous
Subject Etoposide Small molecule 100 mg/m2 Intravenous
Subject Ifosfamide Small molecule 1.67 g Intravenous
Subject Prednisone Other / unclassified 40 mg/m2 Oral
Subject Vincristine Small molecule 1.4 mg/m2 Intravenous

Indications

peripheral T-cell lymphoma, not otherwise specified